Enhanced cartilage regeneration in MIA/CD-RAP deficient mice

Cell Death and Disease

Volumn 1, Issue 11, 2010, Pages

  Schmid, R ^a   Schiffner, S ^a   Opolka, A ^a   Grassel S ^a   Schubert, T ^a   Moser, M ^b   Bosserhoff, A K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Cartilage regeneration; Cell signalling; Differentiation; MIA knockout mouse; MIA CD RAP; Proliferation

Indexed keywords

MELANOMA INHIBITORY ACTIVITY/CARTILAGE DERIVED RETINOIC ACID SENSITIVE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDES AND PROTEINS; PROTEIN P54; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; MIA1 PROTEIN, MOUSE; NUCLEAR MATRIX PROTEIN; P54NRB PROTEIN, MOUSE; RNA BINDING PROTEIN; SCLEROPROTEIN; SOX9 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; FRACTURE HEALING; GENE DISRUPTION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REGENERATION; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; GENETICS; HISTOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REGENERATION;

MUS;

ANIMALS; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROGENESIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; NUCLEAR MATRIX-ASSOCIATED PROTEINS; REGENERATION; RNA-BINDING PROTEINS; SOX9 TRANSCRIPTION FACTOR;

EID: 79958743369     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.78     Document Type: Article

References (27)

1. Blesch A, Bosserhoff AK, Apfel R, Behl C, Hessdoerfer B, Schmitt A et al. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 1994; 54: 5695-5701. (Pubitemid 24346269)
2. van Groningen JJ, Bloemers HP, Swart GW. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res 1995; 55: 6237-6243.
3. Dietz UH, Sandell LJ. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem 1996; 271: 3311-3316. (Pubitemid 26055637)
4. Bosserhoff AK, Stoll R, Sleeman JP, Bataille F, Buettner R, Holak TA. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity. Lab Invest 2003; 83: 1583-1594. (Pubitemid 37421099)
5. Bosserhoff AK, Kondo S, Moser M, Dietz UH, Copeland NG, Gilbert DJ et al. Mouse CDRAP/ MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn 1997; 208: 516-525. (Pubitemid 27152843)
6. Bosserhoff AK, Buettner R. Establishing the protein MIA (melanoma inhibitory activity) as a marker for chondrocyte differentiation. Biomaterials 2003; 24: 3229-3234. (Pubitemid 36577672)
7. Muller-Ladner U, Bosserhoff AK, Dreher K, Hein R, Neidhart M, Gay S et al. MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 148-154. (Pubitemid 29507236)
8. Neidhart M, Muller-Ladner U, Frey W, Bosserhoff AK, Colombani PC, Frey-Rindova P et al. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage 2000; 8: 222-229. (Pubitemid 30304190)
9. Xie WF, Zhang X, Sandell LJ. The 2.2-kb promoter of cartilage-derived retinoic acidsensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. Matrix Biol 2000; 19: 501-509.
10. Moser M, Bosserhoff AK, Hunziker EB, Sandell L, Fassler R, Buettner R. Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. Mol Cell Biol 2002; 22: 1438-1445. (Pubitemid 34150780)
11. Schubert T, Schlegel J, Schmid R, Opolka A, Grassel S, Humphries M et al. Modulation of cartilage differentiation by MIA/CD-RAP. Exp Mol Med 2010; 42: 166-174.
12. Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 2007; 98: 629-635. (Pubitemid 46563437)
13. Kobayashi T, Nakamura E, Shimizu Y, Terada N, Maeno A, Kobori G et al. Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells. Biochem Biophys Res Commun 2009; 387: 196-201.
14. Jin EJ, Choi YA, Sonn JK, Kang SS. Suppression of ADAM 10-induced Delta-1 shedding inhibits cell proliferation during the chondro-inhibitory action of TGF-beta3. Mol Cells 2007; 24: 139-147.
15. Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005; 75: 200-212. (Pubitemid 41456322)
16. Tatzel J, Poser I, Schroeder J, Bosserhoff AK. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes. Pigment Cell Res 2005; 18: 92-101. (Pubitemid 40445045)
17. Hata K, Nishimura R, Muramatsu S, Matsuda A, Matsubara T, Amano K et al. Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice. J Clin Invest 2008; 118: 3098-3108.
18. Bauer R, Humphries M, Fassler R, Winklmeier A, Craig SE, Bosserhoff AK. Regulation of integrin activity by MIA. J Biol Chem 2006; 281: 11669-11677. (Pubitemid 43855424)
19. Tscheudschilsuren G, Bosserhoff AK, Schlegel J, Vollmer D, Anton A, Alt V et al. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA. Exp Cell Res 2006; 312: 63-72. (Pubitemid 41668592)
20. Xie WF, Zhang X, Sakano S, Lefebvre V, Sandell LJ. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 1999; 14: 757-763. (Pubitemid 29210602)
21. Xie WF, Kondo S, Sandell LJ. Regulation of the mouse cartilage-derived retinoic acidsensitive protein gene by the transcription factor AP-2. J Biol Chem 1998; 273: 5026-5032. (Pubitemid 28108659)
22. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006; 14: 13-29. (Pubitemid 43034086)
23. Diermeier S, Schmidt-Bruecken E, Kubbies M, Kunz-Schughart LA, Brockhoff G. Exposure to continuous bromodeoxyuridine (BrdU) differentially affects cell cycle progression of human breast and bladder cancer cell lines. Cell Prolif 2004; 37: 195-206. (Pubitemid 38429330)
24. Poot M, Hoehn H, Kubbies M, Grossmann A, Chen Y, Rabinovitch PS. Cell-cycle analysis using continuous bromodeoxyuridine labeling and Hoechst 33358-ethidium bromide bivariate flow cytometry. Methods Cell Biol 1994; 41: 327-340.
25. Kubbies M. High-resolution cell cycle analysis: the flow cytometric bromodeoxyuridine- Hoechst quenching technique. In: Radbruch A (ed). Flow Cytometry and Cell Sorting, 2nd edn. 1999.
26. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998; 238: 265-272. (Pubitemid 28366150)
27. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ et al. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 2003; 278: 17688-17700. (Pubitemid 36799371)